RTP’s United Therapeutics makes $91M deal to buy Miromatrix Medical


United Therapeutics is buying a Minnesota company that develops bioengineered organs for human transplant.

Previous After big year of funding, Rapport Therapeutics hires a veteran CFO
Next NE Ohio expansion projects net $1.2 million in Ohio tax credits